LGND - Total Utang marang Modal Ligand Corp

Logo perusahaan publik Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals (LGND) protects its business through exclusive platform rights and payments from major industry players under strict FDA supervision. The company operates as a financial hub, collecting royalties without maintaining its own production, which allows it to minimize headcount through automation. The current separate_debt_total_eq ratio stands at 1.15. The trend of this metric is reflected in the company's price chart.

LGND: Total Utang marang Modal Ligand 04.07.2022 - 01.11.2026

Rincian analitis perusahaan Ligand Pharmaceuticals

- rega lan prakiraan konsensus rega:
Bagan rega Ligand|LGND - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Ligand|LGND - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Ligand|LGND - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku ligand.com|LGND - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Ligand Pharmaceuticals|LGND - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Ligand Pharmaceuticals|LGND - Gunggung utang perusahaan|Utang marang nilai buku Ligand|LGND - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ligand|Indikator likuiditas cepet ligand.com
- informasi bathi lan kelipatan valuasi:
LGND - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Ligand
Barang utama Ligand Corp

This ratio reflects the proportion of total liabilities to equity, determining the extent of Ligand Pharmaceuticals (LGND) reliance on borrowed funds. By analyzing the business's leverage ratio, investors assess the company's financial stability, which minimizes capital expenditures through a licensing model and royalty streams, ensuring high scalability without excessive credit pressure.

Analisis pesaing Ligand Pharmaceuticals

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal AMRX (Amneal Pharmaceuticals)|Total Utang marang Modal perrigo.com PRGO|ALVO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Total Utang marang Modal|Total Utang marang Modal amphastar.com|Rasio Total Utang marang Ekuitas PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Theravance TBPH|Aquestive Corp (AQST) - Utang marang Modal|SCPH: Rasio Total Utang marang Ekuitas|Tectonic Therapeutic, Inc. - Utang Agregat marang Modal|TNXP: Total Utang marang Modal|China SXT Pharmaceuticals, Inc. - Rasio Kabeh Utang marang Dana Pribadi|EPRX (Eupraxia Pharmaceuticals, Inc.) - Total Utang marang Modal|Utang marang Modal BioHarvest Sciences Inc BHST|Utang marang Ekuitas eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Entera Bio ENTX|MindWalk Holdings, Inc. - Utang marang Ekuitas|ABVC BioPharma Inc - Total Utang marang Modal|Koefisien Total Utang marang Modal Cumberland Corp CPIX|QNTM: Total Utang marang Modal|Rasio Utang marang Modal fibrogen.com FGEN|TELO (Telomir Pharmaceuticals, Inc.) - Total Utang marang Modal|Total Utang marang Modal Rani Therapeutics Inc|Utang marang Ekuitas Synergy CHC Corp (SNYR)|rallybio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|PULM: Rasio Utang marang Ekuitas|PTHL: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi APM (Aptorum Group Limited)|Lyra Therapeutics, Inc (LYRA) - Utang marang Ekuitas|Utang Agregat marang Ekuitas IBO (Impact BioMedical, Inc.)|TNFA (TNF Pharmaceuticals Inc.) - Total Utang marang Modal|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|Total Utang marang Modal altamiratherapeutics.com (CYTO)|Utang marang Ekuitas Lipella LIPO|Rasio Kabeh Utang marang Dana Pribadi OPTN|PIRS - Utang marang Ekuitas|procapsgroup.com (PROC) - Rasio Total Utang marang Ekuitas|PTPI: Total Utang marang Modal|Qilian International Holding Group (QLI) - Total Utang marang Modal|SLRN (ACELYRIN, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas TFF Pharmaceuticals, Inc (TFFP)